Use of Non-benzodiazepine Hypnotics Is Associated with Decreased Risk of Coronary Artery Disease
スポンサーリンク
概要
- 論文の詳細を見る
Background It has been reported that the use of benzodiazepines (BDZs) is associated with an increased risk of coronary artery disease (CAD). However, it is still unclear whether or not non-BDZs use has the same adverse effect on the cardiovascular system. Methods We conducted a hospital-based case-control study with 864 CAD patients and 1,008 controls to explore the association between non-BDZs use and CAD risk in Chinese Han population. Results Non-BDZs use was found to be associated with a decreased risk of CAD (adjusted odds ratio, OR=0.73; 95% confidence interval, CI=0.54-0.98). Adjusted ORs were 0.91 (95% CI=0.63-1.32) for using non-BDZs 0 to 5 years, 0.64 (95% CI=0.38-0.97) for 5 to 10 years, and 0.42 (95% CI=0.18-0.85) for >10 years. The risk of CAD tended to decrease with an increase in duration of non-BDZs use (p<0.001 for trend). Conclusion Our study demonstrates that non-BDZs use is associated with a decreased risk of CAD. The potential cardiovascular protective mechanisms of non-BDZs should be investigated further.
- 社団法人 日本内科学会の論文
著者
-
Zhou Xiang
Department of Cardiology, The Second Affiliated Hospital of Soochow University, China
-
Zhang Yufeng
Department of Internal Medicine, Jiangyin Hospital of Traditional Chinese Medicine, China
-
Chen Jianchang
Department of Cardiology, The Second Affiliated Hospital of Soochow University, China
-
Xu Weiting
Department of Cardiology, The Second Affiliated Hospital of Soochow University, China
関連論文
- Systematic Off-pump Coronary Artery Bypass
- A novelp. Gly1700Asp mutation in COL7A1 responsible for dominant dystrophic epidermolysis bullosa : More severe phenotype in female members of a Chinese family
- Two Minor Diterpene Glycosides and an Eudesman Sesquiterpene from Coleus forskohlii
- Determination of endocannabinoid receptor antagonist SR141716 (rimonabant) in plasma by liquid chromatograph tandem mass spectrometry
- Retraction: Use of Non-benzodiazepine Hypnotics Is Associated with Decreased Risk of Coronary Artery Disease
- Use of Non-benzodiazepine Hypnotics Is Associated with Decreased Risk of Coronary Artery Disease
- Antiinflammatory Effects of Orientin-2″-O-Galactopyranoside on Lipopolysaccharide-Stimulated Microglia